- Home
- FCT vs CDXS Comparison
FCT vs CDXS Comparison
Compare FCT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCT
- CDXS
- Stock Information
- Founded
- FCT 2004
- CDXS 2002
- Country
- FCT United States
- CDXS United States
- Employees
- FCT N/A
- CDXS N/A
- Industry
- FCT Finance Companies
- CDXS Major Chemicals
- Sector
- FCT Finance
- CDXS Industrials
- Exchange
- FCT Nasdaq
- CDXS Nasdaq
- Market Cap
- FCT 251.8M
- CDXS 216.6M
- IPO Year
- FCT N/A
- CDXS 2010
- Fundamental
- Price
- FCT $9.60
- CDXS $1.65
- Analyst Decision
- FCT
- CDXS Buy
- Analyst Count
- FCT 0
- CDXS 1
- Target Price
- FCT N/A
- CDXS $11.00
- AVG Volume (30 Days)
- FCT 106.8K
- CDXS 672.2K
- Earning Date
- FCT 01-01-0001
- CDXS 11-06-2025
- Dividend Yield
- FCT 11.29%
- CDXS N/A
- EPS Growth
- FCT N/A
- CDXS N/A
- EPS
- FCT N/A
- CDXS N/A
- Revenue
- FCT N/A
- CDXS $57,164,000.00
- Revenue This Year
- FCT N/A
- CDXS $12.88
- Revenue Next Year
- FCT N/A
- CDXS $21.64
- P/E Ratio
- FCT N/A
- CDXS N/A
- Revenue Growth
- FCT N/A
- CDXS N/A
- 52 Week Low
- FCT $9.45
- CDXS $1.90
- 52 Week High
- FCT $10.42
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- FCT 38.45
- CDXS 20.64
- Support Level
- FCT $9.55
- CDXS $2.52
- Resistance Level
- FCT $9.65
- CDXS $2.80
- Average True Range (ATR)
- FCT 0.08
- CDXS 0.14
- MACD
- FCT -0.00
- CDXS -0.09
- Stochastic Oscillator
- FCT 37.02
- CDXS 3.20
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.